Streptococcal A vaccine - ID Biomedical

Drug Profile

Streptococcal A vaccine - ID Biomedical

Alternative Names: GAS vaccine - ID Biomedical; StreptAvax

Latest Information Update: 01 Feb 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Tennessee
  • Developer ID Biomedical Corporation; National Institute of Allergy and Infectious Diseases; University of Tennessee
  • Class Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Streptococcal infections

Most Recent Events

  • 08 Dec 2005 ID Biomedical Corporation has been acquired by GlaxoSmithKline
  • 18 Oct 2005 Data presented at the 43rd Annual Meeting of the Infectious Diseases Society (IDSA-2005) have been added to the adverse events and Bacterial infections immunogenicity sections
  • 28 Jan 2005 Clinical data from a media release have been added to the Bacterial infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top